Skip to content
Screener

McKesson MCK Prescription Technology Solutions — Goodwill

Other segment segments

Oncology & Multispecialty
$3.95B
North American Pharmaceutical
$2.76B
Medical-Surgical Solutions
$2.51B0.0%

Similar metrics at other companies

Nordson logo
NDSNAdvanced Technology Solutions — Goodwill
$449.49M+0.7%
Scansource logo
SCSCSpecialty Technology Solutions — Goodwill
$173.89M+9.3%
DENTSPLY SIRONA logo
XRAYConnected Technology Solutions — Goodwill
$0
The Baldwin Insurance Group, Inc. logo
BWINUnderwriting, Capacity & Technology Solutions — Goodwill
$436.58M
AMN Healthcare logo
AMNTechnology and Workforce Solutions — Goodwill
$368.43M-8.0%
CLB
CLBReservoir Description — Goodwill
$105.79M+6.4%

Other financials

Income statement

See full
Revenue$105.38B+7.7%
Gross profit$3.7B+12.4%
Operating income$1.3B+27.3%
Net income$614.0M-21.7%
EPS (diluted)$5.15-17.6%

Balance sheet

See full
Cash & equivalents$5.3B+95.9%
Total debt$13.0B+15.7%
Total equity-$4.2B-116%
Total assets$88.3B+8.6%

Cash flow

See full
Operating cash flow-$220.0M+76.0%
CapEx$112.0M+0.9%
Free cash flow-$332.0M+67.7%

Valuation

See full
Market cap$102.7B+16.8%
Enterprise value$110.42B+14.5%
P/E22.4×-5.4×
P/S0.3×0.0×

Profitability

See full
Gross margin3.6%+0.1pp
Operating margin1.6%+0.4pp
Net margin1.1%+0.3pp
FCF margin1.6%0.0pp

Returns & leverage

See full
Return on equity36%
Debt / equity
Current ratio0.9×0.0×

Where this comes from

Reported directly by McKesson in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The source filing: McKesson’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:29 PM EDT
Fiscal quarter
Q1 FY2027
Calendar quarter
Q2 2026
Accession
0000927653-26-000234
(In millions)North American PharmaceuticalOncology & MultispecialtyPrescription Technology SolutionsMedical-Surgical SolutionsTotal
Balance, March 31, 2026$2,781$3,963$2,065$2,507$11,316
Goodwill acquired1313
Disposals(2)(2)
Foreign currency translation adjustments, net(26)(26)
Other adjustments (1)(23)(23)
Balance, June 30, 2026$2,755$3,951$2,065$2,507$11,278

Item 1. Condensed Consolidated Financial Statements.

FAQ

What is McKesson's prescription technology solutions — goodwill?
McKesson (MCK) reported prescription technology solutions — goodwill of $2.07B in Q2 2026.
How has McKesson's prescription technology solutions — goodwill changed year-over-year?
McKesson's prescription technology solutions — goodwill decreased by 0.0% year-over-year, from $2.07B to $2.07B.
What is the long-term trend for McKesson's prescription technology solutions — goodwill?
Over 4 years (2022 to 2026), McKesson's prescription technology solutions — goodwill has grown at a 7.6% compound annual growth rate (CAGR), from $6.17B to $8.26B.
What does prescription technology solutions — goodwill mean?
Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations within the Prescription Technology Solutions segment. It serves as an indicator of the segment's historical acquisition activity and the premium paid for market position.

Ask your AI about McKesson's prescription technology solutions — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude